Based on that improvement, we constructed classification models to evaluate if including total chemerin or cleaved chemerin as part of the evaluation of insulin resistance in participants without T2D would be an improvement over use of BMI and FPG alone. The gene discussed is RARRES2; the disease is Insulin resistance.